Lantheus Holdings (LNTH) Interest Coverage Ratio (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Interest Coverage Ratio of 1.66 for Q1 2026, down 61.51% year-over-year from 4.31 in Q1 2025, and down 75.73% quarter-over-quarter from 6.83 in Q4 2025.
Lantheus Holdings (LNTH) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Interest Coverage Ratio for 13 consecutive years, with 1.66 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 61.51% year-over-year to 1.66; the TTM figure through Mar 2026 stood at 5.92 (down 69.02% YoY), while the FY2025 annual figure was 1.72, up 13358.58% from the prior year.
- Interest Coverage Ratio eased to 1.66 in Q1 2026 per LNTH's latest filing, from 6.83 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 340.63 in Q4 2022 and bottomed at 0.37 in Q1 2023.
- Historically, Interest Coverage Ratio has averaged 48.24 across 5 years, with a median of 4.68 in 2024.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio jumped 2911.28% — and 2023, when it tumbled 120.18%.
- Lantheus Holdings' Interest Coverage Ratio stood at 340.63 in 2022, then slipped by 1.31% to 336.15 in 2023, then plunged by 95.95% to 13.61 in 2024, then slumped by 49.77% to 6.83 in 2025, then plunged by 75.73% to 1.66 in 2026.
- Business Quant data shows LNTH's Interest Coverage Ratio at 1.66 in Q1 2026, 6.83 in Q4 2025, and 0.75 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn | 20.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.04 |
| Mar 31, 2026 | 1.66 |
| Dec 31, 2025 | 6.83 |
| Sep 30, 2025 | 0.75 |
| Jun 30, 2025 | 3.72 |
| Mar 31, 2025 | 4.31 |
| Dec 31, 2024 | 13.61 |
| Sep 30, 2024 | 84.70 |
| Jun 30, 2024 | 4.68 |
| Mar 31, 2024 | 6.58 |
| Dec 31, 2023 | 336.15 |
| Sep 30, 2023 | 5.71 |
| Jun 30, 2023 | 4.73 |
| Mar 31, 2023 | -0.37 |
| Dec 31, 2022 | 340.63 |
| Sep 30, 2022 | 2.64 |
| Jun 30, 2022 | 1.94 |
| Mar 31, 2022 | 1.81 |
| Dec 31, 2021 | 11.31 |
| Sep 30, 2021 | -0.44 |